Literature DB >> 14756144

Oxaliplatin.

Joanne Graham, Mohamed Mushin, Peter Kirkpatrick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14756144     DOI： 10.1038/nrd1287

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  57 in total

Review 1.  Review of systemic therapies for locally advanced and metastatic rectal cancer.

Authors:  Patrick Yaffee; Arsen Osipov; Carlyn Tan; Richard Tuli; Andrew Hendifar
Journal:  J Gastrointest Oncol       Date:  2015-04

2.  Towards biomarker-dependent individualized chemotherapy: exploring cell-specific differences in oxaliplatin-DNA adduct distribution using accelerator mass spectrometry.

Authors:  Sang Soo Hah; Paul T Henderson; Kenneth W Turteltaub
Journal:  Bioorg Med Chem Lett       Date:  2010-03-07       Impact factor: 2.823

Review 3.  Cellular senescence and cancer chemotherapy resistance.

Authors:  Ryan R Gordon; Peter S Nelson
Journal:  Drug Resist Updat       Date:  2012-02-23       Impact factor: 18.500

4.  Using a build-and-click approach for producing structural and functional diversity in DNA-targeted hybrid anticancer agents.

Authors:  Song Ding; Xin Qiao; Gregory L Kucera; Ulrich Bierbach
Journal:  J Med Chem       Date:  2012-10-25       Impact factor: 7.446

Review 5.  DNA damage response pathways and cell cycle checkpoints in colorectal cancer: current concepts and future perspectives for targeted treatment.

Authors:  S Solier; Y-W Zhang; A Ballestrero; Y Pommier; G Zoppoli
Journal:  Curr Cancer Drug Targets       Date:  2012-05       Impact factor: 3.428

Review 6.  MicroRNAs are important regulators of drug resistance in colorectal cancer.

Authors:  Yang Zhang; Jing Wang
Journal:  Biol Chem       Date:  2017-07-26       Impact factor: 3.915

7.  The Crystal Structure of Oxaliplatin: A Case of Overlooked Pseudo Symmetry.

Authors:  Timothy C Johnstone
Journal:  Polyhedron       Date:  2014-01-08       Impact factor: 3.052

8.  Analysis of chemotherapy response programs in ovarian cancers by the next-generation sequencing technologies.

Authors:  Lihua Cheng; Wei Lu; Bhushan Kulkarni; Tanja Pejovic; Xiaowei Yan; Jung-Hsien Chiang; Leroy Hood; Kunle Odunsi; Biaoyang Lin
Journal:  Gynecol Oncol       Date:  2010-02-23       Impact factor: 5.482

9.  Bacterial ghosts as adjuvant to oxaliplatin chemotherapy in colorectal carcinomatosis.

Authors:  Diana Groza; Sebastian Gehrig; Pavol Kudela; Martin Holcmann; Christine Pirker; Carina Dinhof; Hemma H Schueffl; Marek Sramko; Julia Hoebart; Fatih Alioglu; Michael Grusch; Manfred Ogris; Werner Lubitz; Bernhard K Keppler; Irena Pashkunova-Martic; Christian R Kowol; Maria Sibilia; Walter Berger; Petra Heffeter
Journal:  Oncoimmunology       Date:  2018-02-16       Impact factor: 8.110

Review 10.  Targeting neuroprotection as an alternative approach to preventing and treating neuropathic pain.

Authors:  Thierry Bordet; Rebecca M Pruss
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.